LexDanaLexDanabeta
Inventor

W. Harry Mandeville, III

Inventor
Lynnfield, MA, US

Overview

71→
Patents
1987–2008
Patent span
Human necessities
Primary field (CPC A)

Patents· 71 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds14%
Y02ATechnologies for adaptation to climate change5%
C08LCompositions of macromolecular compounds5%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds3%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
B29KIndexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials or to materials for moulds, reinforcements, fillers or preformed parts, e.g. inserts2%
B82YSpecific uses or applications of nanostructures2%
C04BLime, magnesia2%
PatentTitleYear
7,459,151'Phosphate-binding polymers for oral administration'20087,399,821'Alkylated poly(allylamine) polymers and methods of use'20087,101,960'Process for removing bile salts from a patient and alkylated compositions therefor'20067,048,917'Fat-binding polymers'20067,049,304'Aryl boronic acids for treating obesity'20067,041,280'Aryl boronate functionalized polymers for treating obesity'20066,875,428'Lipase inhibiting polymers'20056,858,592'Aryl boronic acids for treating obesity'20056,858,203'Method of making phosphate-binding polymers for oral administration'20056,784,254'Process for removing bile salts from a patient and alkylated compositions therefor'20046,767,549'Ionic polymers as anti-infective agents'20046,726,906'Fat-binding polymers'20046,726,905'Poly (diallylamines)-based phosphate binders'20046,692,732'Ionic polymers as toxin-binding agents'20046,605,270'Iron-binding polymers for oral administration'20036,593,366'Ionic polymers as anti-infective agents'20036,572,850'Lipase inhibiting polymers'20036,565,895'Bismuth compounds for the treatment and prevention of mucositis'20036,566,407'Method for reducing oxalate'20036,558,657'Lipase inhibiting polymers'20036,509,013'Method of making phosphate-binding polymers for oral administration'20036,433,026'Process for removing bile salts from a patient and alkylated compositions therefor'20026,423,754'Method for treating hypercholesterolemia with polyallylamine polymers'20026,423,288'Fibrils'20026,395,777'Ionic polymers as anti-infective agents'20026,375,917'Apparatus for the production of carbon fibrils by catalysis and methods thereof'20026,352,692'Lipase inhibiting polymers'20026,299,868'Fat-binding polymers'20016,290,947'Ionic polymers as toxin-binding agents'20016,281,252'Method for reducing oxalate'20016,268,126'Antiviral polymers comprising acid functional groups and hydrophobic groups'20016,267,952'Lipase inhibiting polymers'20016,264,937'Fat-binding polymers'20016,235,720'Acid-functionalized saccharide polymers'20016,225,355'Process for removing bile salts from a patient and alkylated compositions therefor'20016,187,762'Polyvalent polymers for the treatment of rotavirus infection'20016,177,478'Method for reducing oxalate'20016,129,910'Water-insoluble noncrosslinked bile acid sequestrants'20006,083,495'Method of making phosphate-binding polymers for oral administration'20006,066,678'Process for removing bile salts from a patient and alkylated compositions therefor'20006,060,517'Process for removing bile salts from a patient and compositions therefor'20006,060,235'Antiviral polymers comprising acid functional groups and hydrophobic groups'20006,034,129'Ionic polymers as anti-infective agents'20006,007,803'Ionic polymers as toxin binding agents'19995,985,938'Method for reducing oxalate'19995,981,693'Process for removing bile salts from a patient and alkylated compositions therefor'19995,969,090'Hydrophobic sequestrant for cholesterol depletion'19995,939,537'Acid-functionalized saccharide monomers'19995,925,379'Interpenetrating polymer networks for sequestration of bile acids'19995,919,832'Amine polymer sequestrant and method of cholesterol depletion'19995,917,007'Process for removing bile salts from a patient and alkylated compositions therefor'19995,900,475'Hydrophobic sequestrant for cholesterol depletion'19995,891,862'Polyvalent polymers for the treatment of rotavirus infection'19995,877,110'Carbon fibrils'19995,840,766'Process for removing bile salts from a patient and compositions therefor'19985,821,312'Acid-functionalized saccharides as polyvalent anti-infectives'19985,707,916'Carbon fibrils'19985,703,188'Process for removing bile salts from a patient and compositions therefor'19975,702,696'Iron-binding polymers for oral administration'19975,700,458'Acid-functionalized saccharides as polyvalent anti-infectives'19975,693,675'Alkylated amine polymers'19975,679,717'Method for removing bile salts from a patient with alkylated amine polymers'19975,667,775'Phosphate-binding polymers for oral administration'19975,624,963'Process for removing bile salts from a patient and compositions therefor'19975,618,530'Hydrophobic amine polymer sequestrant and method of cholesterol depletion'19975,607,669'Amine polymer sequestrant and method of cholesterol depletion'19975,500,200'Fibrils'19965,496,545'Phosphate-binding polymers for oral administration'19965,487,888'Iron-binding polymers for oral administration'19964,866,205'Prostaglandin intermediates'19894,707,555'Prostaglandin intermediates'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987–1989Patents assigned to HOFFMANN LA ROCHE (2)· patent assignee history
1987–1989Based in Wyckoff, NJ, US· patent location history
1996–2003Patents assigned to GELTEX PHARMA INC (46)· patent assignee history
1996–2002Patents assigned to HYPERION CATALYSIS INT (5)· patent assignee history
1996Patents assigned to GELTEX INC (1)· patent assignee history
1996–2008Based in Lynnfield, MA, US· patent location history
2003–2008Patents assigned to GENZYME CORP (15)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GELTEX PHARMA INC461996–2003
GENZYME CORP152003–2008
HYPERION CATALYSIS INT51996–2002
HOFFMANN LA ROCHE21987–1989
GELTEX INC11996
Locations
LocationPatentsSpan
Lynnfield, Massachusetts, US691996–2008
Wyckoff, New Jersey, US21987–1989